Ftse Mib
33.736,40
-0,03%
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.178,13
1,61%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Femasys Inc (FEMY) Femasys Inc (FEMY) Notizie

FEMY

Femasys (FEMY)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FEMY
DataOraFonteTitoloSimboloCompagnia
18/04/202414:30GlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare InitiativesNASDAQ:FEMYFemasys Inc
28/03/202421:05GlobeNewswire Inc.Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
21/03/202414:00GlobeNewswire Inc.Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment LandscapeNASDAQ:FEMYFemasys Inc
20/03/202413:15GlobeNewswire Inc.Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of InfertilityNASDAQ:FEMYFemasys Inc
13/03/202414:00GlobeNewswire Inc.Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024NASDAQ:FEMYFemasys Inc
06/03/202415:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
06/03/202415:00GlobeNewswire Inc.Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility SolutionNASDAQ:FEMYFemasys Inc
14/02/202403:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
14/02/202403:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
11/12/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FEMYFemasys Inc
08/12/202315:28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
30/11/202323:17Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FEMYFemasys Inc
22/11/202322:12Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:FEMYFemasys Inc
15/11/202314:30Business WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:FEMYFemasys Inc
10/08/202314:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FEMYFemasys Inc
07/08/202314:40Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FEMYFemasys Inc
28/07/202323:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:FEMYFemasys Inc
07/07/202322:26Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:FEMYFemasys Inc
26/06/202314:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FEMYFemasys Inc
16/06/202322:37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FEMYFemasys Inc
16/05/202322:37Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FEMYFemasys Inc
15/05/202312:29Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FEMYFemasys Inc
15/05/202312:29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FEMYFemasys Inc
05/05/202322:02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:FEMYFemasys Inc
28/04/202312:17Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FEMYFemasys Inc
20/04/202315:40Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:FEMYFemasys Inc
05/04/202322:03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FEMYFemasys Inc
30/03/202314:50Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FEMYFemasys Inc
01/12/202221:15TipRanksMaxim Group Keeps Their Buy Rating on Femasys (FEMY)NASDAQ:FEMYFemasys Inc
13/11/202215:30TipRanksAnalysts’ Top Technology Picks: AppLovin (APP), Femasys (FEMY)NASDAQ:FEMYFemasys Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FEMY

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ISP
Intesa Sanpaolo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
SPM
Saipem
BIT
TEN
Tenaris
BIT
AMP
Amplifon
BIT
PRY
Prysmian
BIT
BAMI
Banco BPM
BIT
SRG
Snam
BIT
A2A
A2A
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network